-
IntroducedMar 11, 2026
-
Passed Senate
-
Passed House
-
Became Law
United States Senate Bill
A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Last Action See all actions
Senate • Mar 11, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary
Comments on S 4066
Tweets
Whip Lists
Sponsors
Votes
Actions
- Mar 11, 2026 | Senate
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill Texts
Documents

